Update Swiss guideline for counselling and testing for predisposition to breast, ovarian, pancreatic and prostate cancer

Publikation

Update Swiss guideline for counselling and testing for predisposition to breast, ovarian, pancreatic and prostate cancer

Wissenschaftlicher Artikel/Review - 13.09.2021

Stoll Susanna, Unger Sheila, Azzarello-Burri Silvia, Chappuis Pierre, Graffeo Rossella, Pichert Gabriella, Röthlisberger Benno, Taban Francois, Riniker Salome

Zitation

Stoll S, Unger S, Azzarello-Burri S, Chappuis P, Graffeo R, Pichert G, Röthlisberger B, Taban F, Riniker S. Update Swiss guideline for counselling and testing for predisposition to breast, ovarian, pancreatic and prostate cancer. Swiss Med Wkly 2021; 151:w30038.

Art

Wissenschaftlicher Artikel/Review (Englisch)

Zeitschrift

Swiss Med Wkly 2021; 151

Veröffentlichungsdatum

13.09.2021

eISSN (Online)

1424-3997

Seiten

w30038

Kurzbeschreibung/Zielsetzung

This paper presents the Swiss guideline for genetic counselling and testing of individuals with an increased probability for carrying mutations in high risk cancer predisposition genes, particularly BRCA1 and BRCA2. It aims to help providers of genetic counselling to identify valuable candidates for testing and serves as a basis for reimbursement claims to Swiss insurance companies.